Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protontherapy Guided by [18F]FAZA PET/CT in Chordomas
NCT02802969Phase 2Completed
- Sponsor
- Institut Curie
- Start
- Jul 2016
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fluoroazomycin arabinoside F-18 in chordoma, sponsored by Institut Curie. Started Jul 2016; status: completed.
02
Drugs
Fluoroazomycin arabinoside F-18
03
Conditions
chordoma
Beyond the preview
Go deeper on NCT02802969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02802969.